CLOSE X
GO

Kotak Healthcare Fund-Reg(G)

very highequitypharma & health care
13.46 0.14(1.07%) NAV as on 05 Feb 2025
-6.4 % 1 M
22.97 % 1 Y
NA 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The investment objective of the scheme is to seek to generate long term capital appreciation throughinvesting in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.39

As on 31 Jan, 2025
age-icon Age :

1 yrs 1 m

Since 11 12 ,2023
exit_load Exit Load :

0.5%

aum AUM :

439.02 Crs

lock_in Lock-in :

0.50% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.05

Min_Investment Min. Investment :

SIP 100 & Lumpsum 100

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Shibani Kurian,Abhishek Bisen,Dhananjay Tikariha

LATEST ASSET & PORTFOLIO ALLOCATION

as on Dec 31 ,2024
Others 1.42 %
Equity 98.58 %

TOP HOLDINGS

Sun Pharmaceutical Industries...14.61 %
Cipla Ltd.5.99 %
Divi's Laboratories Ltd.5.00 %
Max Healthcare Institute Ltd.4.29 %
Orchid Pharma Ltd.4.12 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs80.25
Hospital & Healthcare Services18.33
See All Sectors

5-YEARS HISTORY

Financial Year2023-20242024-2025
NAV in Rs (as on 04-Feb-2025)11.3313.32
Net Assets(Rs Crores) (as on 04-Feb-2025) 284.18 439.02
Scheme Returns(%)(Absolute)13.3216.62
B'mark Returns(%)(Absolute)NANA
Category Rank77/9018/98

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Kotak Healthcare Fund-Reg(G)Very HighEquity13.460.14(1.07%)NAV As on 05 Feb, 202511-Dec-2023Inception Date439.02AUM In Cr.22.97%1YNA%3YNA%5Y29.31%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity422.096.90(1.66%)NAV As on 05 Feb, 202514-Jul-1999Inception Date3,628.03AUM In Cr.29.31%1Y23.55%3Y27.76%5Y16.50%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.700.25(0.67%)NAV As on 05 Feb, 202513-Jul-2018Inception Date5,320.29AUM In Cr.29.73%1Y23.52%3Y28.42%5Y22.37%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity30.020.30(1.02%)NAV As on 05 Feb, 202528-Dec-2015Inception Date1,287.45AUM In Cr.24.45%1Y20.41%3Y25.45%5Y12.82%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors